Advanced therapy medicinal products (ATMPs) are a group of innovative biological therapies that have the potential to revolutionise patient care and offer novel approaches for the treatment of disease and injury. Many of these therapies can be curative with a one-off treatment by targeting the root cause of diseases. They present substantial regulatory, technical and logistical challenges, due to lengthy manufacturing processes, complex regulatory procedures and the difficulties of offering medical products with novel routes of administration. This horizon scan provides a comprehensive overview of the clinical development landscape for ATMPs. The scan identifies unique products, clinical trials and developers and provides analysis by ATMP classification. This scan allows health systems to understand the ATMPs which may be coming to market in the future and prepare for the novel challenges they provide.
An Overview of the Clinical Development Landscape for Advanced Therapy Medicinal Products
This horizon scan provides a comprehensive look at the clinical development landscape for advanced therapy medicinal products (ATMPs). We highlight all products that have been or are currently in clinical trials and analyse ATMPs by their classification and product type.